Literature DB >> 6883347

Nonrandom chromosome changes in malignant melanoma.

R Becher, Z Gibas, C Karakousis, A A Sandberg.   

Abstract

Chromosome aberrations were analyzed in 4 cases of malignant melanoma (MM) after disaggregation of the tumors with collagenase and short-term culture. In all cell cultures, the MM cells displayed a typical triangular spindle form. The chromosome number was near-diploid in one case and near-triploid in three cases. A total of 27 abnormal chromosomes were identified with the Giemsa banding technique. By far, the most common types of abnormalities were translocations, followed by deletions and isochromosomes. Chromosomes 1, 6, and 7 were found to be most frequently involved in structural aberrations. Markers originating from chromosomes 1 and 6 were found in all four cases, and abnormalities of chromosome 7 were found in three. Each marker chromosome was unique for a given case; no common markers for two or more cases were found. Based on the present results and an analysis of reports on the chromosomal constitution of MM cells in the literature, we suggest that abnormalities involving chromosomes 6 and 7 may be a characteristic feature of MM. Aberrations of chromosome 1, although common in MM, may be part of a general cytogenetic feature in human neoplasia.

Entities:  

Mesh:

Year:  1983        PMID: 6883347

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  10 in total

1.  Development of five new melanoma low passage cell lines representing the clinical and genetic profile of their tumors of origin.

Authors:  Eleazar Vega-Saenz de Miera; Erica B Friedman; Holly S Greenwald; Mary A Perle; Iman Osman
Journal:  Pigment Cell Melanoma Res       Date:  2012-05       Impact factor: 4.693

2.  Structural alteration in the MYB protooncogene and deletion within the gene encoding alpha-type protein kinase C in human melanoma cell lines.

Authors:  A J Linnenbach; K Huebner; E P Reddy; M Herlyn; A H Parmiter; P C Nowell; H Koprowski
Journal:  Proc Natl Acad Sci U S A       Date:  1988-01       Impact factor: 11.205

3.  Novel amelanotic and melanotic cell lines NM78-AM and NM78-MM derived from a human oral malignant melanoma.

Authors:  Taka Nakahara; Yuichi Tamaki; Noriko Tominaga; Yoshiaki Ide; Masanori Nasu; Akihiro Ohyama; Soh Sato; Isamu Ishiwata; Hiroshi Ishikawa
Journal:  Hum Cell       Date:  2010-02-01       Impact factor: 4.174

Review 4.  Genetic markers on chromosome 7.

Authors:  L C Tsui
Journal:  J Med Genet       Date:  1988-05       Impact factor: 6.318

5.  Chromosome abnormalities in metastatic melanoma.

Authors:  S Rauth; A Green; L Bratescu; T K Das Gupta
Journal:  In Vitro Cell Dev Biol Anim       Date:  1994-02       Impact factor: 2.416

6.  Cytogenetic and molecular genetic studies of follicular and papillary thyroid cancers.

Authors:  M A Herrmann; I D Hay; D H Bartelt; S R Ritland; R J Dahl; C S Grant; R B Jenkins
Journal:  J Clin Invest       Date:  1991-11       Impact factor: 14.808

Review 7.  Cytogenetics of human malignant melanoma.

Authors:  J M Trent
Journal:  Cancer Metastasis Rev       Date:  1991-06       Impact factor: 9.264

Review 8.  Autologous cellular immune response to primary and metastatic human melanomas and its regulation by DR antigens expressed on tumor cells.

Authors:  G Parmiani; G Fossati; D Taramelli; A Anichini; A Balsari; C Gambacorti-Passerini; G Sciorelli; N Cascinelli
Journal:  Cancer Metastasis Rev       Date:  1985       Impact factor: 9.264

9.  Network-guided analysis of genes with altered somatic copy number and gene expression reveals pathways commonly perturbed in metastatic melanoma.

Authors:  Armand Valsesia; Donata Rimoldi; Danielle Martinet; Mark Ibberson; Paola Benaglio; Manfredo Quadroni; Patrice Waridel; Muriel Gaillard; Mireille Pidoux; Blandine Rapin; Carlo Rivolta; Ioannis Xenarios; Andrew J G Simpson; Stylianos E Antonarakis; Jacques S Beckmann; C Victor Jongeneel; Christian Iseli; Brian J Stevenson
Journal:  PLoS One       Date:  2011-04-08       Impact factor: 3.240

Review 10.  NUAK2: an emerging acral melanoma oncogene.

Authors:  Takeshi Namiki; Sergio G Coelho; Vincent J Hearing
Journal:  Oncotarget       Date:  2011-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.